UCSF News Office

Media Coverage

Spotlight

September 14, 2009

Bloomberg News cites UCSF research on genetic testing for HER2

New research on the limited amount of testing for HER2 gene expression in breast cancer patients is covered in a Sept. 14 article by Bloomberg News, which cites the research led by health policy professor Kathryn Phillips, PhD, from the UCSF School of Pharmacy. Phillips, who is director of the UCSF Center for Translational and Policy Research on Personalized Medicine, was lead author of a paper in the Sept. 14 issue of the journal Cancer, which found that two-thirds of women with invasive breast cancer are never tested to see whether they overexpress the HER2 gene, despite the potential effectiveness of the drug Herceptin for those patients.

http://www.bloomberg.com/apps/news?pid=20601103&sid=a6BSznpQUiks#